期刊文献+

蛋白质组学在卵巢癌肿瘤标志物研究中的应用与进展

原文传递
导出
摘要 蛋白质组学是后基因组时代的一个重要内容,其理论与技术的发展和完善为人类疾病的研究带来了新的思维方式。蛋白质组学的主要研究内容可分为表达蛋白质组学和功能蛋白质组学。
出处 《中国妇幼保健》 CAS 北大核心 2011年第34期5463-5465,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献17

  • 1Conrads TP, Hood BL, Issaq HJ et al. Proteomic patterns as a diagnos- tic tool for early - stage cancer: a review of its progress to a clinically relevant tool [J] . Mol Diagn, 2004, 8 (2) : 77.
  • 2Petricoin EF, Liotta LA. SELDI TOF - based serum proteomic pattern diagnostics for early detection of cancer [ J ]. Curr Opin Biotechnol, 2004, 15 (1): 24.
  • 3Wisztorski M, Lemaire R, Stauber J. New developments in MALDI ima- ging for pathology proteomic studies [ J ] . Curr Pharm Des, 2007, 13 (32) : 3317.
  • 4胡越,蔡莲莲,耿筱虹,温怀凯,孙静,徐肖文.血清CA125、癌胚抗原及甲胎蛋白鉴别附件肿块良恶性的价值[J].现代中西医结合杂志,2003,12(15):1571-1573. 被引量:4
  • 5Kim JH, Skates SJ, Uede T et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer [J]. JAMA, 2002, 287 (13) : 1671.
  • 6Nakae M, Lwamoto I, Fujino T et al. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in pre- dicting ovarian cancer [J]. J Obstet Gynaecol Res, 2006, 32 ( 3 ) : 309.
  • 7Mrochem J, Sodowski K, Deja R et al. Evaluation of selected serum pro- tein markers as early detectors of ovarian cancer [J]. Ginekol Pol, 2008, 79 (4): 271.
  • 8Camlica H, Duranyildiz D, Tas F et al. Statistical interpretation of CA125 and Bcl - 2 in serum of patients with late stage ovarian cancer [J] . American Journal of Clinical Oncology, 2008, 31 (6) : 585.
  • 9Petricion EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer [ J ]. Lancet, 2002, 359 (9306) : 572.
  • 10Kong F, White NC, Xiao X. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer [J] . Gynecol Oncol, 2006, 100 (2): 247.

二级参考文献16

  • 1朱祯敏,胡晓芳,曾嵘,邵志敏,徐学敏.血清蛋白质组学在乳腺癌研究中的应用[J].中华肿瘤杂志,2007,29(8):561-565. 被引量:4
  • 2Kupesic S, Vujisic S, Kurjak A, et al. Preoperative assessment of ovarian tumors by CA125 measurement and transvaginal color Doppler ultrasound[J]. Acta Med Croatica, 2002, 56(1) : 3 - 10.
  • 3Bast RC, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J]. N Engl J Med, 1983, 309(3) : 169- 171.
  • 4Kurawski VP, Orjaseter H, Andersen A, et al. Elevated serum CA125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer[J]. Int J cancer, 1988, 42(5) :677 - 807.
  • 5Nicoletta C, Toon VG, Gabriella P, et al. Ovarian cancer [ J]. Oncol hematol,2006,60 : 159-179
  • 6Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002[ J]. CA Cancer J Clin,2005,55:74-108
  • 7Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[ J ]. Anal Biochem, 1976,72 : 248-254
  • 8Thompson S, Dargan E, Turner GA. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer[ J]. Cancer Lett, 1992,66:43-48
  • 9Ye B, Cramer DW, Skates SJ, et al. Haptoglobin-alphasubunit as potential serum biomarker in ovarian cancer:identification and characterization using proteomic profiling and mass spectrometry [ J ]. Clin Cancer Res, 2003,9 : 2904- 2911
  • 10Durra LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium [ J ]. Trends Cell Biol, 2007,17:93-100

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部